Suppr超能文献

Bevacizumab and Temozolomide Plus Radiation Regimen for Glioblastoma Multiforme.

作者信息

Rutledge Matthew R, Waddell J Aubrey, Solimando Dominic A

机构信息

Chief, Hematology-Oncology Pharmacy Service, Department of Pharmacy, Madigan Army Medical Center , Tacoma, Washington . The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the US Department of the Army or the Department of Defense.

出版信息

Hosp Pharm. 2015 Sep;50(8):672-7. doi: 10.1310/hpj5008-672. Epub 2015 Sep 16.

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net.

摘要

相似文献

1
Bevacizumab and Temozolomide Plus Radiation Regimen for Glioblastoma Multiforme.
Hosp Pharm. 2015 Sep;50(8):672-7. doi: 10.1310/hpj5008-672. Epub 2015 Sep 16.
2
Gemcitabine and Vinorelbine (GemVin) Regimen.
Hosp Pharm. 2014 Jun;49(6):508-16. doi: 10.1310/hpj4906-508.
3
nab-Paclitaxel Plus Gemcitabine Regimen for Pancreatic Cancer.
Hosp Pharm. 2014 Jan;49(1):18-22. doi: 10.1310/hpj4901-18.
4
Cabazitaxel and Prednisone Regimen for Prostate Cancer.
Hosp Pharm. 2015 Jun;50(6):460-3. doi: 10.1310/hpj5006-460.
5
Dinutuximab and Panobinostat.
Hosp Pharm. 2015 Oct;50(9):767-72. doi: 10.1310/hpj5009-767. Epub 2015 Oct 14.
6
Nivolumab and Olaparib.
Hosp Pharm. 2015 May;50(5):356-66. doi: 10.1310/hpj5005-356.
7
Blinatumomab and Pembrolizumab.
Hosp Pharm. 2015 Apr;50(4):269-73. doi: 10.1310/hpj5004-269. Epub 2015 Apr 8.
8
Gefitinib and Sonidegib.
Hosp Pharm. 2015 Nov;50(10):868-872. doi: 10.1310/hpj5010-868. Epub 2015 Nov 19.
9
Lenvatinib and Palbociclib.
Hosp Pharm. 2015 Jul;50(7):578-82. doi: 10.1310/hpj5007-578. Epub 2015 Jul 31.
10
Enzalutamide and ruxolitinib.
Hosp Pharm. 2013 Feb;48(2):104-7. doi: 10.1310/hpj4802-104.

引用本文的文献

本文引用的文献

1
3
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
Clin Cancer Res. 2014 Oct 1;20(19):5023-31. doi: 10.1158/1078-0432.CCR-14-0822. Epub 2014 Aug 8.
4
Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline.
Curr Oncol. 2014 Jun;21(3):e493-503. doi: 10.3747/co.21.1769.
5
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
N Engl J Med. 2014 Feb 20;370(8):709-22. doi: 10.1056/NEJMoa1308345.
6
A randomized trial of bevacizumab for newly diagnosed glioblastoma.
N Engl J Med. 2014 Feb 20;370(8):699-708. doi: 10.1056/NEJMoa1308573.
8
A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma.
J Neurosurg. 2012 Feb;116(2):341-5. doi: 10.3171/2011.9.JNS11656. Epub 2011 Oct 28.
9
Antiemetics: American Society of Clinical Oncology clinical practice guideline update.
J Clin Oncol. 2011 Nov 1;29(31):4189-98. doi: 10.1200/JCO.2010.34.4614. Epub 2011 Sep 26.
10
Corticosteroids in brain cancer patients: benefits and pitfalls.
Expert Rev Clin Pharmacol. 2011 Mar;4(2):233-42. doi: 10.1586/ecp.11.1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验